BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24583758)

  • 21. Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis.
    Miyaji H; Ito S; Azuma T; Ito Y; Yamazaki Y; Ohtaki Y; Sato F; Hirai M; Kuriyama M; Kohli Y
    Gut; 1997 Jun; 40(6):726-30. PubMed ID: 9245925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Helicobacter pylori eradication on blood ammonia levels in cirrhotic patients: a systematic review.
    Qin SY; Jiang HX; Ning HJ; Nie HM; Tao L; Hu BL; Guo XY
    Hepatogastroenterology; 2012; 59(120):2576-81. PubMed ID: 22591680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori eradication for hepatic encephalopathy treatment: the ideal study is still lacking!
    Zullo A; Ridola L; De Francesco V; Hassan C
    J Clin Gastroenterol; 2015 Jan; 49(1):88-9. PubMed ID: 25485514
    [No Abstract]   [Full Text] [Related]  

  • 24. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
    Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
    Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.
    Mitrică D; Pleşa A; Constantinescu R; Drug V; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):367-74. PubMed ID: 21870725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Helicobacter pylori eradication on serum ammonia levels in patients with chronic liver disease.
    Nandakumar R; Naik AS; Pandit B; Kamat R; Bhatia SJ
    Indian J Gastroenterol; 2003; 22(6):221-3. PubMed ID: 15030034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimal Hepatic Encephalopathy: Effect of H. pylori infection and small intestinal bacterial overgrowth treatment on clinical outcomes.
    Abid S; Kamran M; Abid A; Butt N; Awan S; Abbas Z
    Sci Rep; 2020 Jun; 10(1):10079. PubMed ID: 32572109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Helicobacter pylori with the Risk of Hepatic Encephalopathy.
    Wijarnpreecha K; Chesdachai S; Thongprayoon C; Jaruvongvanich V; Ungprasert P; Cheungpasitporn W
    Dig Dis Sci; 2017 Dec; 62(12):3614-3621. PubMed ID: 29119412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori and the liver: any relationship?
    Farinati F; De Bona M; Floreani A; Foschia F; Rugge M
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):124-8. PubMed ID: 9615280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Updates in the pathogenesis and diagnosis of hepatic encephalopathy.
    Haliga R; Didita A; Anton C; Sorodoc L
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):601-7. PubMed ID: 25341271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients.
    Scotiniotis IA; Lucey MR; Metz DC
    Dig Dis Sci; 2001 Dec; 46(12):2744-51. PubMed ID: 11768268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients.
    Zullo A; Rinaldi V; Meddi P; Hassan C; Winn S; Attili AF
    Am J Gastroenterol; 1999 Aug; 94(8):2214-8. PubMed ID: 10445552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indications for treatment of Helicobacter pylori infection: a systematic overview.
    Veldhuyzen van Zanten SJ; Sherman PM
    CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of Helicobacter pylori eradication on gastric juice and blood ammonia concentrations and on visual evoked potentials in cirrhotics.
    Demirtürk L; Yazgan Y; zci O; Ozel M; Toğrol E; Gültepe M; Gürbüz AK; Yildirim S
    Helicobacter; 2001 Dec; 6(4):325-30. PubMed ID: 11843965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimum duration of regimens for Helicobacter pylori eradication.
    Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastritis and Helicobacter pylori: forty years of antibiotic therapy.
    Lieber CS
    Digestion; 1997; 58(3):203-10. PubMed ID: 9243114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in serum ammonia concentration in cirrhotic patients with Helicobacter pylori infection.
    Si J; Cao Q; Gao M; Fang L; Qian G; Wang Y
    Chin Med J (Engl); 2000 Dec; 113(12):1080-1. PubMed ID: 11776140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori, hyperammonemia, and hepatic encephalopathy: is there a correlation?
    Rinaldi V; Zullo A; Diana F; Capocaccia L
    Am J Gastroenterol; 1997 Apr; 92(4):723-4. PubMed ID: 9128348
    [No Abstract]   [Full Text] [Related]  

  • 39. Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis.
    Yuan LT; Chuah SK; Yang SC; Liang CM; Wu CK; Tai WC; Hung TH; Nguang SH; Wang JW; Tseng KL; Ku MK; Hsu PI; Wu DC; Hsu CN
    PLoS One; 2018; 13(5):e0197127. PubMed ID: 29746564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.
    Moayyedi P; Deeks J; Talley NJ; Delaney B; Forman D
    Am J Gastroenterol; 2003 Dec; 98(12):2621-6. PubMed ID: 14687807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.